The following two tables show the 2025 committee chairs, track chairs, and conference advisors. For a brief history of the NCB Conference,
click here.
|
Committee Member
|
Company
|
Role
|
|
Paul Faya
|
Eli Lilly
|
Co-chair
|
|
John Kolassa
|
Rutgers
|
Co-chair
|
|
Aili Cheng
|
Pfizer
|
CMC section chair
|
|
Jeonifer Garren
|
Pfizer
|
Discovery/Biomarkers section chair
|
|
Yushi Liu
|
Eli Lilly
|
Safety/Pharmacology section chair
|
|
Ondrej Libeger
|
Janssen
|
Computing/visualization section chair
|
|
Phillip Yates
|
BMS
|
Posters
|
|
Jyh-ming Shoung
|
J&J
|
Students
|
|
Wei Zhao
|
AstraZeneca
|
Students
|
|
Angel Lu
|
PharmaLex
|
Best Nonclinical paper award
|
|
Richard Baumgartner
|
Merck
|
Publicity
|
|
Advisors
|
Company
|
Role
|
|
Xin Huang
|
AbbVie
|
Past chair
|
|
Steven Novick
|
Eli Lilly
|
Past chair
|
|
Buffy Hudson-Curtis
|
GSK
|
Past Section chair
|
|
Jason Zhang
|
AstraZeneca
|
Past Section chair
|
|
Binbing Yu
|
AstraZeneca
|
Past Section chair
|
|
Kjell Johnson
|
Stat Tenacity
|
Past Section chair
|
|
Yi Tsong
|
FDA
|
Regulatory
|
|
Don Bennett
|
Pfizer
|
emeritus - Past chair
|
|
Tony Lonardo
|
Eli Lilly
|
Advisor emeritus
|
|
Stan Altan
|
J&J
|
Advisor emeritus
|